Show notes
Pharma/AOR Executives: Make sure you grab a complimentary copy of our 3-Step Guide To Using the Netflix-Like Content Hubs to Engage HCPs in 30-90 Days 👉 3-Step Free Guide
In this episode, Bozidar is joined by Miriam Meeuwissen, Managing Director at Launch & Lifecycle Biopharma.
They cover:
In this episode, Bozidar is joined by Miriam Meeuwissen, Managing Director at Launch & Lifecycle Biopharma.
They cover:
- What are the three critical components for value creation in the life cycle of a product?
- What does value creation mean in pharma launches?
- What is the difference between must-have and innovative treatment value creators?
- How do digital and agile methodologies help pharma organizations streamline and improve their go-to-market strategies?
Subscribe here:
- Apple: https://apple.co/3micGmF
- Google Podcasts: https://bit.ly/3PUds6T
- Spotify: https://spoti.fi/3M78XCC
- RSS: https://bit.ly/3wTksIm
And connect with the host and guest here:
- Bozidar Jovicevic: https://www.linkedin.com/in/bjovicevic
- Evermed: https://evermedtv.com
- Miriam Meeuwissen: https://www.linkedin.com/in/miriam-meeuwissen
- Launch & Lifecycle Biopharma: https://launchlifecycle.com
About The Show:
“Pharma Launch Secrets” is a podcast by Evermed and hosted by CEO Bozidar Jovicevic. We host direct, actionable conversations with world-leading pharma launch experts and help you stay up-to-date with the latest trends and strategies to help you launch your product successfully.
Check out our three most downloaded episodes:
- Omnichannel and CDP (Customer Data Platforms): What Every Pharma Marketer Needs To Know About Using Data To Enable Seamless Customer Experience, Drive Engagement, And Lift Rx
- Greatest Hits: A Look Back on Five of the Best Pharma Launch Secrets Episodes
- Launch Planning in a Digital-First Reality: How Can a Traditional “Reach and Frequency” Model Be Adapted to an Omnichannel Future?
If you are interested in joining Pharma Launch Secrets as a guest, please visit this link: start.evermedtv.com/podcast-apply/
